...
首页> 外文期刊>Disease markers >Oxidized Low-Density Lipoprotein Cholesterol and the Ratio in the Diagnosis and Evaluation of Therapeutic Effect In Patients with Coronary Artery Disease
【24h】

Oxidized Low-Density Lipoprotein Cholesterol and the Ratio in the Diagnosis and Evaluation of Therapeutic Effect In Patients with Coronary Artery Disease

机译:氧化型低密度脂蛋白胆固醇及其在冠心病患者诊断和治疗效果评估中的比例

获取原文
           

摘要

Objective: The purpose of the present study was to investigate the value of ox-LDL and oxidation ratio of LDL (ox-LDL/TC, ox-LDL/HDL-C and ox-LDL/LDL-C) in diagnosis and prognosis evaluation in CAD patients. Also, we aimed to observe the effect of statins on reducing level of ox-LDL and oxidation ratio of LDL, and explore whether statins still have similar effect on ox-LDL in a short period of therapy (within 2 weeks).Methods: Blood ox-LDL, TC, HDL-C, LDL-C, and TG were measured in cases with acute myocardial infarction (AMI,n=177), unstable angina pectoris (UAP,n= 195), stable angina pectoris (SAP,n= 228), normal control (n= 120), and high riskcontrol (n= 140).Results: Mean value of ox-LDL and oxidation ratio of LDL was significantly higher in the CAD group than in the two control groups. The AUC of ROC curve of ox-LDL, ox-LDL/TC, ox-LDL/HDL-C, ox-LDL/LDL-C and apoA1/apoB were more than 0.50 (P< 0.001). Multivariate logistic regression analysis showed that age and ox-LDL/LDL-C related with short-term, while ox-LDL/LDL-C and ox-LDL/TC related with long-term prognosis (P< 0.05). Furthermore, after treatment with statins for 2 weeks, TC, LDL-C, ox-LDL, ox-LDL/TC, ox-LDL/HDL-C and ox-LDL/LDL-C decreased by 22%, 28%, 38%, 29%, 23% and 25% respectively. And the reduction of ox-LDL by statins is independent of lowering of LDL-C and TC.Conclusions: Ox-LDL and oxidation ratio of LDL are closely related with AS, and they are better biomarkers for discriminatingbetween patients with coronary artery disease and healthy subjects. In addition, statins can decrease level of ox-LDL significantly,which is independent of lowering of LDL-C and TC.
机译:目的:本研究旨在探讨ox-LDL的价值和LDL的氧化率(ox-LDL / TC,ox-LDL / HDL-C和ox-LDL / LDL-C)在诊断和预后评估中的价值在CAD患者中。此外,我们旨在观察他汀类药物对降低ox-LDL水平和降低LDL氧化率的作用,并探讨他汀类药物在短期治疗(2周内)对ox-LDL仍然具有相似的作用。在急性心肌梗死(AMI,n = 177),不稳定型心绞痛(UAP,n = 195),稳定型心绞痛(SAP,n)的患者中测量ox-LDL,TC,HDL-C,LDL-C和TG = 228),正常对照组(n = 120)和高风险对照组(n = 140)。结果:CAD组中ox-LDL的平均值和LDL的氧化率显着高于两个对照组。 ox-LDL,ox-LDL / TC,ox-LDL / HDL-C,ox-LDL / LDL-C和apoA1 / apoB的ROC曲线的AUC大于0.50(P <0.001)。多元logistic回归分析显示,年龄和ox-LDL / LDL-C与短期相关,而ox-LDL / LDL-C和ox-LDL / TC与长期预后相关(P <0.05)。此外,在他汀类药物治疗2周后,TC,LDL-C,ox-LDL,ox-LDL / TC,ox-LDL / HDL-C和ox-LDL / LDL-C降低了22%,28%,38分别为%,29%,23%和25%。结论:Ox-LDL和LDL的氧化率与AS密切相关,是区分冠心病和健康人的更好的生物标志物。结论:他汀类药物降低ox-LDL与LDL-C和TC的降低无关。科目。此外,他汀类药物可显着降低ox-LDL的水平,这与降低LDL-C和TC无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号